Evidence map›Paper›PMID 35807494›Full record

ArticleMolecules (Basel, Switzerland)2022

Push-Pull Derivatives Based on 2,4'-Biphenylene Linker with Quinoxaline, [1,2,5]Oxadiazolo[3,4-

Egor V Verbitskiy, Pascal le Poul, Filip Bureš, Sylvain Achelle, Alberto Barsella, Yuriy A Kvashnin, Gennady L Rusinov, Valery N Charushin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Egor V VerbitskiyI. Postovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, S. Kovalevskaya Str., 22, 620108 Ekaterinburg, Russia.ORCID 0000-0002-1482-206X
Pascal le PoulUniversity Rennes, CNRS, Institut des Sciences Chimiques de Rennes-UMR 6226, 35000 Rennes, France.
Filip BurešInstitute of Organic Chemistry and Technology, Faculty of Chemical Technology, University of Pardubice Studenská 573, 53210 Pardubice, Czech Republic.ORCID 0000-0002-2832-6673
Sylvain AchelleUniversity Rennes, CNRS, Institut des Sciences Chimiques de Rennes-UMR 6226, 35000 Rennes, France.ORCID 0000-0002-9226-7735
Alberto BarsellaDépartement d'Optique Ultrarapide et Nanophotonique, IPCMS, UMR CNRS 7504, Université de Strasbourg, 23 rue du Loess, BP 43, CEDEX 2, 67034 Strasbourg, France.ORCID 0000-0002-3707-9221
Yuriy A KvashninI. Postovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, S. Kovalevskaya Str., 22, 620108 Ekaterinburg, Russia.
Gennady L RusinovI. Postovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, S. Kovalevskaya Str., 22, 620108 Ekaterinburg, Russia.
Valery N CharushinI. Postovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, S. Kovalevskaya Str., 22, 620108 Ekaterinburg, Russia.ORCID 0000-0002-9140-358X

Funding

Russian Science Foundation 19-13-00234
6 · The paper itself

Abstract

A series of novel V-shaped quinoxaline, [1,2,5]oxadiazolo[3,4-

Indexed as

[1,2,5]thiadiazolo[3,4-b]pyrazinedonor–acceptor systemsfurazanopyrazinequinoxalinetwisted intramolecular charge transfer

Identifiers

PMID35807494
PMCPMC9268487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.